Company

Sling Therapeutics

https://www.slingtx.com/

Industryclinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED)

Funding raised

CompanyRoundDate
Sling TherapeuticsSeries C2026-09-16